St. Jude Medical Inc. (NYSE:STJ) won CE Mark approval for its Athena deep-brain stimulation programmer, designed to help physicians control the amount of current delivered to patients’ brains to treat Parkinson’s disease.

The St. Paul, Minn.-based medical device maker said the latest iteration of the programmer also allows doctors to store up to 200,000 patient records. It’s designed to work with St. Jude’s Libra, LibraXP and Brio DBS systems, according to a press release.

There’s a DBS donnybrook brewing in the Twin Cities, as St. Jude and crosstown rival Medtronic Inc. (NYSE:MDT) battle for space in the market. Medtronic last week won CE Mark approval for its Activa DBS system for epilepsy. In March, St. Jude landed Australian approval for its BRIO device for Parkinson’s.